Arkolith/Insider Trading/TRAW/Form 4

Savchuk Nikolay

Chief Operating Officer, Director, 10% OwnerTraws Pharma, Inc. (TRAW) · full profile →Form 4 · filed Jan 27, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 29, 2024Buy(P)96K——96K
Dec 29, 2024Buy(P)96K——96K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-006406) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML